Xu Hou

8PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsAutoimmunityMedical biochemistry - proteins and peptides (incl. medical proteomics)Toxicology (incl. clinical toxicology)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Phosphorylated ubiquitin is a secondary messenger and an epigenetic mark mediating mitochondria to nucleus signaling.

|Jul 01, 2024
NLRP3 inflammasome activation and altered mitophagy are key pathways in inclusion body myositis.

Elie Naddaf, Thi Kim Oanh Nguyen, Jens O Watzlawik

|May 27, 2024
Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue.

Jens O Watzlawik, Xu Hou, Tyrique Richardson

|May 15, 2024
Alterations of PINK1-PRKN signaling in mice during normal aging.

Zahra Baninameh, Jens O Watzlawik, Xu Hou

|Jan 31, 2024
Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue.

Jens O Watzlawik, Xu Hou, Tyrique Richardson

|Jun 01, 2023
Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent.

Xu Hou, Taylor Hsuan-Yu Chen, Shunsuke Koga

Pageof 2

Frequent Collaborators

4 joint publications

Fabienne C Fiesel

3 joint publications

Wolfdieter Springer

1 joint publications

Ayman H Faroqi

1 joint publications

Jaroslaw Dulski